We serve Chemical Name:4-Bromo-2-chloro-1-methylbenzene CAS:89794-02-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:4-Bromo-2-chloro-1-methylbenzene
CAS.NO:89794-02-5
Synonyms:Benzene, 4-bromo-2-chloro-1-methyl-;MFCD00060651;4-Bromo-2-chloro-1-methylbenzene
Molecular Formula:C7H6BrCl
Molecular Weight:205.480
HS Code:2903999090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:220.5±20.0 °C at 760 mmHg
Density:1.5±0.1 g/cm3
Index of Refraction:1.566
PSA:
Exact Mass:203.934128
LogP:3.99
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:NONH for all modes of transpor
Packing Group:
Contact us for information like Benzene, 4-bromo-2-chloro-1-methyl- chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4-Bromo-2-chloro-1-methylbenzene physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Benzene, 4-bromo-2-chloro-1-methyl- Use and application,MFCD00060651 technical grade,usp/ep/jp grade.
Related News: Steven M. Fruchtman, M.D., President and Chief Executive Officer of Onconova, added ��The rigosertib Pre-approval Access Program is a key strategic initiative for Onconova. 4-Bromo-2-chloro-1-methylbenzene manufacturer As Reuters reported last month, Lilly tapped the Washington D.C. law firm Covington & Burling LLP to investigate the alleged alterations, which the employees said were meant to downplay serious quality control problems at the plant producing the drugmaker’s COVID-19 antibody treatment. 4-Bromo-2-chloro-1-methylbenzene supplier We also have to consider the degree of concentration and which temperature allows a high quality of API to be manufactured efficiently. 4-Bromo-2-chloro-1-methylbenzene vendor The chemical compound which is in the process of becoming an API from a raw material is called an intermediate. 4-Bromo-2-chloro-1-methylbenzene factory Steven M. Fruchtman, M.D., President and Chief Executive Officer of Onconova, added ��The rigosertib Pre-approval Access Program is a key strategic initiative for Onconova.
